Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54]
1 Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA; Fundacion Instituto Valenciano Oncologia, Valencia, Spain. Electronic address: [email protected].
2 Departmentof Medical, Oral and Biotechnological Sciences, Urology Unit, University "G. d'Annunzio", Chieti-Pescara, Italy.
3 Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
4 Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
5 University of Alberta, Edmonton, Alberta, Canada.
6 Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
7 Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
8 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, University of Münster, Münster, Germany.
9 Department of Urology, University of Oklahoma College of Medicine, Oklahoma City, OK, USA.
10 Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA.
11 Department of Urology, University of Michigan Health System, Ann Arbor, MI, USA.
12 Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.
13 Department of Medicine, Division of Oncology, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
14 Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, NY, USA; Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris, France.
15 Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK.
16 Department of Surgery (Division of Urology), McGill University Health Center, Montreal, Canada.
17 Department of Urology, University of California at Davis, Davis Medical Center, Sacramento, CA, USA.
18 Princess Margaret Hospital, Toronto, Ontario, Canada.
19 Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK.
20 Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, NY, USA; Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria; UT Southwestern, Dallas, TX, USA; Charles University, Prag, Czech Republic; University of Jordan, Amman, Jordan.
21 Department of Urology, University of Washington, Seattle, WA, USA.
22 Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, MD, USA.
23 Cross Cancer Institute, Edmonton, AB, Canada; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
24 Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
25 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
26 Department of Medicine, Division of Oncology, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
27 Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Urology, RUSH University, Chicago, IL, USA.
28 Department of Urology, MD Anderson Cancer Center, Houston, TX, USA; Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.
29 USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, CA, USA.